Sigma Legal, jointly led by Stéphanie Chuffart-Finsterwald and Alain Alberini, is noted for its ‘excellent expertise and high quality advice’, assisting a diverse client base of biotech companies, home care entities, and medical institutions. The group regularly handles licensing agreements, in addition to advising on e-health and medical apps. In Geneva, Chuffart-Finsterwald is known for her extensive regulatory knowledge of healthcare and medical law, regularly assisting clients with mandates involving health data and medical secrecy. Working out of the Lausanne office, Alberini is well versed in handling a wide variety of issues, including patient rights and consent forms, and researcher labour agreements.
Testimonials
Collated independently by Legal 500 research team.
‘I found them to be engaged, empathetic and very professional. They took time to analyse all the documents, the history of the problem we were having and proposed carefully thought through solutions and strategies. They were clearly knowledgeable about intellectual property issues and dealing with the problem in different jurisdictions, which were both very helpful.’
‘The team actively listens and promptly seeks to grasp the problem's context, employing a dedicated mindset to approach solutions. They effectively participated in an activity that might not have been directly aligned with their core expertise. This reflected a mutual agreement and openness to engage in new initiatives that we recognised as an innovative initiative, strengthening our collaboration.’
Key clients
- World Health Organization
- MindMaze SA
Work highlights
- Advised Mindmaze on medical devices regulations under Swiss law. The client is active in digital neurotherapy, at the crossroad of health sciences, IT (including medicals softwares) and entertainment.
- Advising the World Health Organization on issues relating to public health, in particular advice on matters relating to the Covid-19 Therapeutics Solidarity Trial and the Covid-19 vaccines Solidarity Trial; the establishment of the COVAX No-Fault Compensation Program for AMC Eligible Economies; and issues pertaining to R&D, IT, and sensitive privacy and data protection matters. The team assisted with strategy planning, the drafting of agreements, and the preparation of other documents of a legal nature as required by WHO.